Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism
Stefan Selch, Anja Chafai, Heinrich Sticht, Andreas L Birkenfeld, Martin F Fromm, Jörg König, Stefan Selch, Anja Chafai, Heinrich Sticht, Andreas L Birkenfeld, Martin F Fromm, Jörg König
Abstract
The human uptake transporter NaCT is important for human brain development, brain function and energy metabolism and mediates the uptake of citrate and other intermediates of the tricarboxylic acid cycle from blood into neurons and hepatocytes. Mutations in the SLC13A5 gene encoding NaCT are associated with epileptic encephalopathy. To gain more insights into the transport mechanisms we analyzed the functional consequences of mutations in the SLC13A5 gene on NaCT-mediated transport function. Using HEK293 cells expressing wild-type and eight mutated NaCT proteins, we investigated the mRNA and protein amount as well as the protein localization of all NaCT variants. Furthermore, the impact on NaCT-mediated citrate uptake was measured. In addition, a structural model of the transport pore was generated to rationalize the consequences of the mutations on a structural basis. We demonstrated that all proteins were synthesized with an identical molecular weight as the wild-type transporter but several mutations (NaCTp.G219R, -p.G219E, -p.T227M, -p.L420P and -p.L488P) lead to a complete loss of NaCT-mediated citrate transport. This loss of transport activity can be explained on the basis of the developed structural model. This model may help in the further elucidation of the transport mechanism of this important uptake transporter.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- Hediger MA, et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch. 2004;447:465–468. doi: 10.1007/s00424-003-1192-y.
- Pajor AM. Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family. Pflugers Arch. 2014;466:119–130. doi: 10.1007/s00424-013-1369-y.
- Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem. 2002;277:39469–39476. doi: 10.1074/jbc.M207072200.
- Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium action. Biochem J. 2003;374:21–26. doi: 10.1042/bj20030827.
- Zwart R, Peeva PM, Rong JX, Sher E. Electrophysiological characterization of human and mouse sodium-dependent citrate transporters (NaCT/SLC13A5) reveal species differences with respect to substrate sensitivity and cation dependence. J Pharmacol Exp Ther. 2015;355:247–254. doi: 10.1124/jpet.115.226902.
- Neretti N, et al. Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage. Proc Natl Acad Sci USA. 2009;106:2277–2282. doi: 10.1073/pnas.0812484106.
- Schwarz F, et al. Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2. Aging (Albany NY) 2015;7:553–567. doi: 10.18632/aging.100791.
- Wang PY, et al. Long-lived Indy and calorie restriction interact to extend life span. Proc Natl Acad Sci USA. 2009;106:9262–9267. doi: 10.1073/pnas.0904115106.
- Rogers RP, Rogina B. Increased mitochondrial biogenesis preserves intestinal stem cell homeostasis and contributes to longevity in Indy mutant flies. Aging (Albany NY) 2014;6:335–350. doi: 10.18632/aging.100658.
- Birkenfeld AL, et al. Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab. 2011;14:567–567. doi: 10.1016/j.cmet.2011.09.005.
- Irizarry AR, et al. Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice. PloS One. 2017;12:e0175465. doi: 10.1371/journal.pone.0175465.
- Thevenon J, et al. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am J Hum Genet. 2014;95:113–120. doi: 10.1016/j.ajhg.2014.06.006.
- Hardies K, et al. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. Brain. 2015;138:3238–3250. doi: 10.1093/brain/awv263.
- Klotz, J., Porter, B. E., Colas, C., Schlessinger, A. & Pajor, A. M. Mutations in the Na+/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay. Mol Med 22, 10.2119/molmed.2016.00077 (2016).
- Anselm I, MacCuaig M, Prabhu SB, Berry GT. Disease heterogeneity in Na+/Citrate cotransporter deficiency. JIMD Rep. 2016;31:107–111. doi: 10.1007/8904_2016_546.
- Mancusso R, Gregorio GG, Liu Q, Wang DN. Structure and mechanism of a bacterial sodiumdependent dicarboxylate transporter. Nature. 2012;491:622–626. doi: 10.1038/nature11542.
- Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB, IARC Unclassified Genetic Variants Working Group. In silico analysis of missense substitutions using sequence-alignment based methods. Hum. Mutat. 2008;29:1327–1336. doi: 10.1002/humu.20892.
- von Loeffelholz C, et al. The human longevity gene homolog INDY and Interleukin-6 interact in hepatic lipid metabolism. Hepatology. 2017;66:616–630. doi: 10.1002/hep.29089.
- Schlessinger A, Sun NN, Colas C, Pajor AM. Determinants of substrate and cation transport in the human Na+/dicarboxylate cotransporter NaDC3. J Biol Chem. 2014;289:16998–17008. doi: 10.1074/jbc.M114.554790.
- Bergeron MJ, Clemencon B, Hediger MA, Markovich D. SLC13 family of Na+-coupled di- and tricarboxylate/ sulfate transporters. Mol Aspects Med. 2013;34:299–312. doi: 10.1016/j.mam.2012.12.001.
- Rodrigues TB, Valette J, Bouzier-Sore AK. 13C NMR spectroscopy applications to brain energy metabolism. Frontiers in neuroenergetics. 2013;5:9. doi: 10.3389/fnene.2013.00009.
- Glaeser H, Mandery K, Sticht H, Fromm MF, König J. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3. Br J Pharmacol. 2010;159:698–708. doi: 10.1111/j.1476-5381.2009.00568.x.
- Huber S, et al. Esters of Bendamustine are by far more potent cytotoxic agents than the parent compound against human sarcoma and carcinoma cells. PloS One. 2015;10:e0133743. doi: 10.1371/journal.pone.0133743.
- Seithel A, et al. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos. 2007;35:779–786. doi: 10.1124/dmd.106.014407.
- Colas C, Pajor AM, Schlessinger A. Structure-Based identification of inhibitors for the SLC13 Family of Na+/Dicarboxylate cotransporters. Biochemistry. 2015;54:4900–4908. doi: 10.1021/acs.biochem.5b00388.
- Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2014;47(5):1–32.
- Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck - a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291. doi: 10.1107/S0021889892009944.
- Hooft RWW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature. 1996;381:272–272. doi: 10.1038/381272a0.
- Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 1997;18:2714–2723. doi: 10.1002/elps.1150181505.
- Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph Model. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5.
- Claros MG, von Heijne G. TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci. 1994;10:685–686.
- Senger M, Glatting KH, Ritter O, Suhai S. X-HUSAR, an X-based graphical interface for the analysis of genomic sequences. Comput Methods Programs Biomed. 1995;46:131–141. doi: 10.1016/0169-2607(94)01610-R.
Source: PubMed